PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF UPADACITINIB IN CHILDREN WITH ATOPIC DERMATITIS

被引：0
|
作者：
Qian, Y. [1 ]
Raymundo, E. [1 ]
Hao, S. [1 ]
Unnebrink, K. [2 ]
Liu, J. [1 ]
Teixeira, H. [1 ]
Chu, A. [1 ]
Paller, A. [3 ]
Liu, W. [1 ]
Mohamed, M. [1 ]
机构：
[1] AbbVie, N Chicago, IL USA
[2] AbbVie DeutschIand GmbH & Co KG, Ludwigshafen, Germany
[3] Northwestern Univ, Chicago, IL USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2023年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII-114
引用
收藏
页码：S78 / S78
页数：1
相关论文
共 50 条
  • [21] Oral Upadacitinib Beats Subcutaneous Dupilumab for Atopic Dermatitis
    Slomski, Anita
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (13): : 1246 - 1246
  • [22] Safety of upadacitinib in moderate-to-severe atopic dermatitis: An integrated analysis of phase 3 studies
    Guttman-Yassky, Emma
    Thyssen, Jacob P.
    Silverberg, Jonathan I.
    Papp, Kim A.
    Paller, Amy S.
    Weidinger, Stephan
    Hong, H. Chih-ho
    Hendrickson, Barbara
    Dilley, Deanne
    Tenorio, Allan R.
    Ladizinski, Barry
    Chu, Alvina D.
    Liu, John
    Irvine, Alan D.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (01) : 172 - 181
  • [23] Atopic Dermatitis and Ulcerative Colitis Successfully Treated with Upadacitinib
    Grieco, Teresa
    Caviglia, Martina
    Cusano, Giuseppina
    Sernicola, Alvise
    Chello, Camilla
    Del Duca, Ester
    Cantisani, Carmen
    Taliano, Alberto
    Sini, Nicolo
    Ianiro, Gianluca
    Pellacani, Giovanni
    MEDICINA-LITHUANIA, 2023, 59 (03):
  • [24] Metabolic effects of upadacitinib in patients with psoriasis and atopic dermatitis
    Posada, Marielos I. Posada
    Alora, Maria Beatrice
    Lima, Xinaida Taligare Vasconcelos
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2024, 316 (05)
  • [25] EFFICACY AND SAFETY OF UPADACITINIB FOR ATOPIC DERMATITIS IN DUPILUMAB NON-RESPONDERS: A MULTICENTER RETROSPECTIVE STUDY
    Georgakopoulos, Jorge R.
    Sheka, Dropen
    Rankin, Brian
    Maliyar, Khalad
    Rimke, Alexander
    Prajapati, Vimal H.
    Yeung, Jensen
    ACTA DERMATO-VENEREOLOGICA, 2023, 103 : 16 - 16
  • [26] Atopic Dermatitis: Upadacitinib more effective than Dupilumab
    Metzger, Leandra
    AKTUELLE DERMATOLOGIE, 2021, 47 (12) : 521 - 521
  • [27] Retreatment with upadacitinib in atopic dermatitis: experience in clinical practice
    Martinez-Fernandez, S.
    Suh-Oh, H. J.
    Batalla, A.
    Couselo-Rodriguez, C.
    Espasandin-Arias, M.
    Florez, A.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2023, 34 (01)
  • [28] Tolerability of Topical Treatments for Atopic Dermatitis
    Zoe D. Draelos
    Steven R. Feldman
    Brian Berman
    Melissa Olivadoti
    Debra Sierka
    Anna M. Tallman
    Michael A. Zielinski
    William C. Ports
    Sheryl Baldwin
    Dermatology and Therapy, 2019, 9 : 71 - 102
  • [29] Tolerability of Topical Treatments for Atopic Dermatitis
    Draelos, Zoe D.
    Feldman, Steven R.
    Berman, Brian
    Olivadoti, Melissa
    Sierka, Debra
    Tallman, Anna M.
    Zielinski, Michael A.
    Ports, William C.
    Baldwin, Sheryl
    DERMATOLOGY AND THERAPY, 2019, 9 (01) : 71 - 102
  • [30] Treatment of Severe Atopic Dermatitis With Upadacitinib in Clinical Practice: Short-Term Efficacy and Safety Results
    Pereyra-Rodriguez, J. J.
    Herranz, P.
    Figueras-Nart, I
    Perez, B.
    Elosua, M.
    Munera-Campos, M.
    Melgosa-Ramos, J.
    Zaragoza, V
    Silvestre, J. F.
    Campos-Dominguez, M.
    Guilabert, A.
    Miquel, J.
    Alcantara-Luna, S.
    de la Cueva, P.
    Serra-Baldrich, E.
    Armario-Hita, J. C.
    Rodriguez, Jose Juan Pereyra
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2023, 33 (03) : 211 - 213
12345